The mechanisms underlying these results are based on the activity of GLP-1 in controlling eating, acting on satiety signals [92] in areas of the brain involved in food intake regulation [93] and peripheral action, reducing gastric emptying and intestinal motility, and slowing absorption [94]
Sweet spot = 2501000 mg/day because studies show that it increases glutathione levels by 17-35% (IJDVL) Timing also matters
Saxenda, znana rwnie pod swoj nazw generyczn liraglutyd, jest nowoczesnym lekiem stosowanym w leczeniu otyoci
A personalized assessment will help determine if GLP-1 is the right option for you based on your specific health conditions, medical history, and treatment goals
Indication: type 2 diabetes (T2D)
" " '' , 25 16 5 AAIC [AAIC] [AAIC] , [ASPAC 2024] ASPAC 2024 , 3D ' ?..., 2025 10 , GLP-1 ... , ?